SUMMARY In a study using a non-serological enzymatic approach for the detection of Neisseria gonorrhoeae in cervical and urethral swabs, the technique was shown to be technically feasible. The enzyme, 1, 2-propanediol oxidoreductase, was used as a presumptive diagnostic marker for N gonorrhoeae. Enzymatic activity was measured with a fluorometer. Two assay procedures were performed: (a) enzyme detection (two-tube and three-tube assays) requiring 60 minutes; and (b) enzyme inhibition (EI) (90-minute and modified 20-minute assays). Sensitivities of the two-tube, three-tube, and the 90-minute EI assays with male urethral specimens from a high-prevalence population were 80'7o, 84%, and 81 % respectively. The specificities of these assays in a lowprevalence male population were not determined. Sensitivity of the 90-minute EI assay in a highprevalence female group was 77% and specificity in a low-prevalence female group was 75%. The modified EI assay was tested only in a low-prevalence female group and had 87%o specificity. Although the specificity of the assays needs improvement, several advantages-including early case detection, rapid availability of results, detection of current active infections, and the possibility of automation-are intrinsic in this enzymatic approach.
Introduction
Cultural isolation and identification are the most definitive diagnostic means presently available for detecting gonorrhoea in women and will very likely continue to be the principal diagnostic procedures in the foreseeable future.' Any test which can rapidly determine the presence of an active gonococcal infection would be an invaluable adjunct.
Recently, we reported the isolation and characterisation of a previously undescribed enzyme, 1, 2-propanediol oxidoreductase, from Neisseria gonorrhoeae. 2 Examination of various microorganisms in the female genital tract showed that appreciable concentrations of this particular enzyme were present in only Neisseria and Acinetobacter species.2 Of these organisms, N gonorrhoeae showed higher levels of activity than most of the other organisms. We In a two-tube assay, 0 5 ml of patient sample (described below) was mixed with 2-5 ml of 0 1 mol/l Tris buffer, pH 9 0, containing 0-25 mol/l NH4Cl, 5-02 mmol/l nicotinamide adenine dinucleotide (NAD), and 0-438 mmol/l 1, 2-propanediol. A control tube contained the same constituents with the exception of the 1, 2-propanediol. After incubation for one hour at 50°C, a fluorometer (Turner Model 111, Turner Associates, Palo Alto, California) was calibrated to zero with the control tube. The propanediol oxidoreductase activity in the test tube was then measured and expressed as fluorescence units (fu) per ml of patient sample.
A three-tube assay was also used, in which the twotube assay was expanded to include a third tube with patient sample and Tris buffer containing NH4Cl, NAD, and 0 362 mmol/l glycerol. The assay was conducted as above with the enzymatic activities in the propanediol and in the glycerol tubes being measured. The activity with the glycerol was then subtracted from the activity with propanediol to yield the net fu/ml with this three-tube assay.
INHIBITION OF PROPANEDIOL OXIDOREDUCTASE
Initially a 0 5-ml volume of patient sample was added to each of two tubes: one tube contained 0 1 ml normal goat serum and one tube, 0 1 ml of goat anti-propanediol oxidoreductase serum. Preparation and characterisation of this goat antiserum is described elsewhere.3 After incubation for 30 minutes at room temperature (24°C), 2 4 ml of 0-1 mol/l Tris buffer containing 0 25 mol/l NH4Cl, 5-02 mmol/l NAD, and 0-438 mmol/l 1, 2-propanediol were added to both tubes. These were then incubated for one hour at 50°C. A fluorometer was calibrated to zero with the immune serum tube. The activity in the normal serum tube was then measured. This assay was referred to as the 90-minute enzyme inhibition (EI) assay.
Eventually, the procedure was modified as follows to reduce the total assay time: I 0 ml of patient sample and 0 2 ml of normal or immune goat serum were used. Both tubes were incubated for five minutes at 24°C. Then, 0 5 ml of Tris buffer containing the same concentrations of NH4C1, NAD, and propanediol as before were added to each tube. The tubes were incubated for 15 minutes at 50°C and read in the fluorometer as before.
PATIENT SAMPLES Urethral swabs from 121 male patients from a population in which the prevalence of gonorrhoea 305 was at least 32% were tested initially. These samples were collected with cotton-tipped swabs, which were first used for cultural diagnosis then for enzyme assays. Subsequent studies used separate calcium alginate swabs for culture and for enzyme assays.
Cervical swabs from 117 women in a highprevalence (32%) group and from 100 women in a low-prevalence (2%) group were tested. All swabs were placed immediately in 2-5 ml Tris-cysteine buffer and were refrigerated until tested. Time lapse between collection of samples and testing ranged from I 5 to five hours. Swabs were mixed in the buffer, squeezed against the inside of the tube to remove as much buffer as possible, and discarded. This buffer (or patient sample) was then subjected to the enzyme assays.
INTERPRETATION OF FLUORESCENCE UNITS
To maximise assay efficiency interpretative criteria in fluorescence units (fu) were established statistically and defined as the agreement between the enzyme assay and cultural results in a hypothetical 50/50 mixture of positive and negative samples. The criteria for each assay were: in the two-tube assay, fu > 5 was positive and fu> 4 was negative; in the three-tube assay, fu >. 2 was positive and fu . 1 was negative; and in the 90-minute enzyme inhibition assay, fu > 1 (> 2 in the modified 20-minute procedure) was positive and fu = 0 (. 1 in the modified procedure) was negative.
SENSITIVITY AND SPECIFICITY
The sensitivity and specificity of our assay were computed assuming the cultural method had 100% sensitivity and specificity. In this paper, we have described a new nonserological enzymatic assay for the detection of N gonorrhoeae. This approach could overcome some of the major disadvantages of both the cultural method and serological tests.
Like most laboratory tests which analyse a clinical specimen, a result with this enzymatic approach depended to a large extent on the condition of the specimen examined. Initial efforts in this study were therefore concerned with the development of a reliable transport system for genital secretions. Our results indicated that the Tris-cysteine buffer was an excellent means of transporting specimens, during which time gonococci were lysed and propanediol oxidoreductase activity was maintained.
Experiments with pure gonococcal lysates suggested that this enzymatic approach was capable of detecting low concentrations of gonococci. These concentrations were within the range suggested as the required sensitivity of a test for non-viable gonococcal antigens in clinical specimens."
Results of the initial trial with male specimens indicated that the sensitivity of all three assays compared favourably with many of the documented serological tests.'0 Improved sensitivity may have been observed if swabs that had not been used previously for culture had been tested.
Since a low-prevalence male group was not tested, the exact specificities of these assays were not known and accurate comparison with serological tests was not possible. However, it is reasonable to assume that male swabs will not contain the diverse types and numbers of organisms which may crossreact in the assays and which may be present in female swabs. Thus, the 92-977o specificity observed in the highprevalence group may be indicative of the specificity in a low-prevalence male group.
In the second and third trials, we concentrated on female specimens, since this is where a rapid, noncultural test would be most advantageous. We used the inhibition approach because we considered our goat antiserum would promote specificity and not affect sensitivity. In the high-prevalence group, the sensitivity of the 90-minute assay was 77%, which is within the range of sensitivities reported for serological tests.'" This sensitivity is also approximately equivalent to the 80% sensitivity generally assumed for the cultural method.8 Unfortunately, the modified assay was not tested in this population.
The observed sensitivity however coupled with other advantages, such as the rapid availability of test results and the non-dependency on antibodyresponse time should lead to early detection and treatment of cases of gonorrhoea. Furthermore, only current active infections should be detected as persistent antigonococcal antibodies present after treatment should not interfere.
Both the 90-minute and the modified El assays were tested in a low-prevalence female group. Although only two culture-positive samples were tested, the modified assay appeared to be more sensitive than the 90-minute assay. The specificities of the modified assay and of the 90-minute assay in this low-prevalence group were 87% and 75% respectively. Therefore, many false-positive results were observed. Possibly, many of these may not have been caused by microbial crossreactivity but were due to non-microbial factors such as cervical tissues or enzymes or by unresolved technical factors in the methodology. Alternatively, false-positive results by our assay in these comparative studies with culture results may not necessarily have all been incorrect. The sensitivity of our cultural procedure was not determined. Also, cultural results may have been falsely negative since sensitivity on culture may be as low as 40% .8 This would have severely affected the estimate of our specificity. Nonetheless, a specificity of nearly 1001o must be attained for the assay to be truly effective in screening programmes.
In summary, these studies have shown the promise of a novel and rapid approach for the detection of N gonorrhoeae in urethral and cervical specimens. Further studies and comprehensive clinical evaluation are needed to perfect this approach.
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